Scientific associate

 

AG Medical Statistics

Phone: +49(0)221 478 33403

E-Mail @ uni-koeln.de: kija.shah

 

 

Research Focus

• Open-label randomised controlled trial designs
• Non-interventional studies (NIS)
• Patient preferences in randomised clinical trials

Responsibilities

• Statistical analysis of clinical trials
• Teaching coordinator of the Institute of Medical Statistics and Computational Biology
• Teaching in Epidemiology, Medical Statistics and Medical Informatics
• Randomisation of clinical trials

Education

• Dr. rer. nat. (PhD) awarded by the Faculty of Mathematics and Natural Sciences at the University of Cologne with research focus on human genetics and molecular tumor biology
• Dr. rer. medic. (DMedSc) awarded by the Faculty of Medicine at the University of Cologne with research focus on clinical trials and allergology
• Diploma in Biology from the Faculty of Mathematics and Natural Sciences at the University of Oldenburg with research focus on genetics and microbiology
• Master of Science in Medical Biometry/Biostatistics from the Faculty of Medicine at the University of Heidelberg with research focus on open-label randomised controlled study designs

Publications

2024

Oberste M, Asenova T, Ernst A, Shah-Hosseini K, Schnörch N, Buess M, Rosenberger KD, Kossow A, Dewald F, Neuhann F, Hellmich M
Results of the Cologne Corona Surveillance (CoCoS) project - a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection, and moderate-to-severe course in primarily immunized adults.
BMC Public Health 24, 548 (2024 Feb 21). doi: 10.1186/s12889-024-17958-4

2023

Kruse C, Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, van der Wurp H, Dodel R, Jessen F
Apathy in patients with Alzheimer's disease is a cost-driving factor.
Alzheimers Dement. 2023 Jan 2. doi: 10.1002/alz.12915. Epub ahead of print. PMID: 36588502

Oberste M, Schnörch N, Shah-Hosseini K, Asenova T, Dewald F, Lehmann C, Buess M, Fätkenheuer G, Klein F, Rosenberger KD, Kossow A, Neuhann F, Hellmich M
Results of the Cologne Corona Surveillance (CoCoS) study – a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection in adults.
BMC Public Health 23, 260 (2023 Feb 6). doi: 10.1186/s12889-023-15047-6

2022

Oberste M, Pusch LM, Roth R, Shah-Hosseini K, Schmitz J, Heger E, Dewald F, Müller C, von Goltzheim LS, Lehmann C, Buess M, Wolff A, Fätkenheuer G, Wiesmüller G, Klein F, Rosenberger KD, Neuhann F, Hellmich M
Results of the Cologne Corona surveillance (CoCoS) study - a prospective population-based cohort study: incidence data and potential underestimation of new SARS-CoV-2 adult infections by health authorities.
BMC Public Health. 2022 Jul 19;22(1):1379. doi: 10.1186/s12889-022-13745-1. PubMed PMID: 35854283

Voltz R, Boström K, Dojan T, Rosendahl C, Gehrke L, Shah-Hosseini K, Kremeike K
Is trained communication about desire to die harmful for patients receiving palliative care? A cohort study.
Palliat Med. 2022 Mar;36(3):489-497. doi: 10.1177/02692163211065671. Epub 2021 Dec 22. PubMed PMID: 34937431

2021

Joachim A, Dewald F, Suárez I, Zemlin M, Lang I, Stutz R, Marthaler A, Bosse HM, Lübke N, Münch J, Bernard MA, Jeltsch K, Tönshoff B, Weidner N, Kräusslich HG, Birzele L, Hübner J, Schmied P, Meyer-Bühn M, Horemheb-Rubio G, Cornely OA, Haverkamp H, Wiesmüller G, Fätkenheuer G, Hero B, Kaiser R, Dötsch J, Rybniker J; B-FAST study group (Cosgun ZC, Hünseler C, Schönenkorb J, Wurm J, Klein F, Heger E, Knops E, Sierra-Aragón S, Kretschmer AC, Sprute R, Kossow A, Hellmich M, Shah-Hosseini K, Weiss M, Goedicke-Fritz S, Kaiser E, Meyer S, Seiwert N, Smola S, Pfuhl T, Lohse S, Schupp AK, Timm J, Gröne N, Lesmann H, Bredahl R, Schneble L, Turinsky M, Patry C, Hoffmann GF, Müller B, Börner K, Schnitzler P, Heuser AM, Welker A, von Both U, Kern A)
Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial.
EClinicalMedicine. 2021 Sep;39:101082. PMID: 34458708. doi: 10.1016/j.eclinm.2021.101082

Oberste M, Pusch LM, Roth R, Shah-Hosseini K, Dewald F, Müller C, Stach von Goltzheim L, Lehmann C, Buess M, Wolff A, Fätkenheuer G, Wiesmüller G, Klein F, Hellmich M, Neuhann F
Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.
BMC Public Health. 2021 Jul 2;21(1):1295. PMID 34215236. doi: 10.1186/s12889-021-11206-9

Schick V, Boensch M, van Edig M, Alfitian J, Pola T, Ecker H, Lindacher F, Shah-Hosseini K, Wetsch WA, Riedel B, Schier R
Impaired vascular endothelial function as a perioperative risk predictor - a prospective observational trial.
BMC Anesthesiol. 2021 Jul 15;21(1):190. PMID: 34266384. DOI: 10.1186/s12871-021-01400-y

Voggel J, Lubomirov L, Lechner F, Fink G, Nüsken E, Wohlfarth M, Pfitzer G, Shah-Hosseini K, Hellmich M, Alcázar MAA, Dötsch J, Nüsken KD
Vascular tone regulation in renal interlobar arteries of male rats is dysfunctional after intrauterine growth restriction.
Am J Physiol Renal Physiol. 2021 May 31. PMID 34056927. doi: 10.1152/ajprenal.00653.2020

2020

Kremeike K, Frerich G, Romotzky V, Boström K, Dojan T, Galushko M, Shah-Hosseini K, Jünger S, Rodin G, Pfaff H, Perrar K M, Voltz R
The desire to die in palliative care: a sequential mixed methods study to develop a semi-structured clinical approach.
BMC Palliat Care. 2020 Apr 16;19(1):49. doi: 10.1186/s12904-020-00548-7

Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027

2019

Nieber K, Raskopf E, Möller J, Kelber O, Fürst R, Shah-Hosseini K, Singh J, Kraft K, Mösges R
Pharmaco-epidemiological research on herbal medicinal products in the paediatric population: data from the PhytoVIS study.
Eur J Pediatr. 2019 Dec 11. doi: 10.1007/s00431-019-03532-3

Salem L, Dao VA, Shah-Hosseini K, de Marees M, Mester J, Mösges R, Vent J
Impaired sports performance of athletes suffering from pollen-induced allergic rhinitis: a cross-sectional, observational survey in German athletes.
J Sports Med Phys Fitness. 2019 Apr;59(4):686-692. doi: 10.23736/S0022-4707.18.08556-0

Dao VA, Acikel C, Shah-Hosseini K, Vent J, Raskopf E, Mösges R
Inadequate knowledge of allergen immunotherapy among athletes with allergic rhinitis: a post hoc analysis.
Allergy. 2019 May 23. doi: 10.1111/all.13922

Mösges R, Breitrück NY, Allekotte S, Shah-Hosseini K, Dao VA, Zieglmayer P, Birkholz K, Hess M, Bastl M, Bastl K, Berger U, Kramer MF, Guethoff S
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season.
World Allergy Organ J. 2019 Mar 8;12(2):100012. doi: 10.1016/j.waojou.2019.100012

Grzella AN, Schleicher S, Shah-Hosseini K, Astvatsatourov A, Raskopf E, Allekotte S, Mösges R
Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing.
Int Arch Allergy Immunol. 2019;179(2):123-131. doi: 10.1159/000496938

Tran BH, Dao VA, Bilstein A, Unfried K, Shah-Hosseini K, Mösges R
Ectoine-Containing Inhalation Solution versus Saline Inhalation Solution in the Treatment of Acute Bronchitis and Acute Respiratory Infections: A Prospective, Controlled, Observational Study.
Biomed Res Int. 2019 Jan 31;2019:7945091. doi: 10.1155/2019/7945091

2018

Köther J, Mandl A, Allekotte S, Astvatsatourov A, Chwieralski J, Liedtke JP, Pieper-Fürst U, Raskopf E, Shah-Hosseini K, Mösges R
Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy.
Clin Transl Allergy. 2018 Jul 4;8:28. doi: 10.1186/s13601-018-0214-y

Liedtke JP, Mandl A, Köther J, Chwieralski J, Shah-Hosseini K, Pieper-Fürst U, Allekotte S, Mösges R
RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients.
Allergy. 2018 May;73(5):1101-1109. doi: 10.1111/all.13362

Mösges R, Koch AF, Raskopf E, Singh J, Shah-Hosseini K, Astvatsatourov A, Hauswald B, Yarin Y, Corazza F, Haazen L, Pirotton S, Allekotte S, Zadoyan G, Legon T, Durham SR, Shamji MH
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
Allergy. 2018 Jun;73(6):1254-1262. doi: 10.1111/all.13392

Mösges R, Kasche EM, Raskopf E, Singh J, Sohlich L, Astvatsatourov A, Shah-Hosseini K, Pirotton S, Haazen L, Durham SR, Legon T, Zadoyan G, Shamji MH
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
Allergy. 2018 Apr;73(4):896-904. doi: 10.1111/all.13358

Pieper-Fürst U, Dao VA, Shah-Hosseini K, Panin G, Lamprecht J, Mösges R
Alpha-tocopherol acetate nasal spray in the treatment of pollen-induced allergic rhinitis. Comparison of a medical device to beclomethasone nasal spray and loratadine in a prospective, controlled, observational study.
Allergo J Int (11/2018), doi.org/10.1007/s40629-018-0086-7

Schüller H, Allekotte S, Shah-Hosseini K, Mösges R, Berger UE
Analyse: Papierbasierte oder elektronische Tagebücher als Dokumentationsform? - Eine Beobachtungsstudie zur Symptomlast bei Heuschnupfenpatienten.
Deutsche Zeitschrift für klinische Forschung, Innovation und Praxis (DZKF), 4. 2018, 22. Jahrgang, S.26-32

2017

Mösges R, Rohdenburg C, Eichel A, Zadoyan G, Kasche EM, Shah-Hosseini K, Lehmacher W, Schmalz P, Compalati E
Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
Immunotherapy. 2017 Nov;9(15):1225-1238. doi: 10.2217/imt-2017-0058

Mösges R, Shah-Hosseini K, Hucke HP, Joisten J
Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays.
Advances in Therapy, 2017 Jul, DOI: 10.1007/s12325-017-0581-0

Pfaar O, Lang S, Pieper-Fürst U, Astvasatourov A, Gerich F, Klimek L, Kramer MF, Reydelet Y, Shah-Hosseini K, Mösges R
Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinitis.
Allergy, 2017 Jul, DOI: 10.1111/all.13240

Shah-Hosseini K, Krudewig EM, Hadler M, Karagianis E, Mösges R
Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Result of a 2-Year Real-Life Study.
Advances in Therapy, 2017 Jun, DOI: 10.1007/s12325-017-0535-6

Lemberg ML, Berk T, Shah-Hosseini K, Kasch EM, Mösges R
Sublingual versus subcutaneous immuntherapy: patient adherence at a large German allergy center.
Patient Prefer Adherence, 2017 Jan, DOI: 10.2147/PPA.S122948

2016

Lutz JT, Diener IV, Freiberg K, Zillmann R, Shah-Hosseini K, Seifert H, Berger-Schreck B, Wisplinghoff H
Efficacy of two antiseptic regimens on skin colonization of insertion sites for two different catheter types: a randomized, clinical trial.
Infection, 2016 Dec;44(6):707-712

Lemberg ML, Eberle P, Shah-Hosseini K
Importance of Quality of Life for Adherence to Sublingual Immunotherapy.
Biomed Res Int, Vol. 2016, Article ID 5186765

Müller D, Lindemann T, Shah-Hosseini K, Scherner O, Knop M, Bilstein A, Mösges R
Efficacy and tolerability of an ectoine mouth and throut spray compared with those of saline Iozenges in the treatment of acute pharyngitis and/ or laryngitis: a prospective, controlled observational trail.
Eur Arch Otorhinolaryngol, 2016 Apr

Hüser C, Dieterich P, Singh J, Shah-Hosseini K, Allekotte S, Lehmacher W, Compalati E, Mösges R
A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite allergic patients.
Allergy, 2016 Apr, DOI: 10.1111/all.12913

Nguyen NT, Raskopf E, Shah-Hosseini K, Zadoyan G, Mösges R
A review of allergoid immuntherapy: is cat allergy a suitable target?
Immunotherapy, 2016 Feb, DOI: 10.2217/imt.15.121

2015

Shah-Hosseini K, Mioc K, Hadler M, Karagianis E, Mösges R
Optimum Treatment Strategies of Polyallergic Patients - Analysis of a Large Observational Trial.
Current Medical Research and Opinion, 2015 Sep 14:1-33

Kruse K, Gerwin E, Eichel, Shah-Hosseini K, Mösges R
Conjunctival Provocation Tests: A Predictive Factor for Patients' Seasonal Allergic Rhinoconjunctivitis Symptoms.
J Allergy Clin Immunol Pract., 2015 Jan 22; pii: S2213-2198(14)

2014

Larenas-Linnemann D, Michels A, Dinger H, Shah-Hosseini K, Mösges R, Mexican Study Group on Allergic Rhinitis and SPT Sensitivity
Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropics.
Clinical and Translational Allergy, 2014 Jun 4;4:20

Gouteva I, Shah-Hosseini K, Meiser P
Clinical Efficacy of a Spray Containing Hyaluronic Acid and Dexpanthenol after Surgery in the Nasal Cavity (Septoplasty, Simple Ethmoid Sinus Surgery, and Turbinate Surgery).
Journal of Allergy, Volume 2014 (2014), Article ID 635490

Larenas-Linnemann D, Michels A, Dinger H, Mexican Study Group on Allergic Rhinitis and SPT Sensitivity, Shah-Hosseini K, Mösges R
In the (sub)tropics Allergic Rhinitis and Its Impact on Asthma classification of allergic rhinitis is more useful than perennial-seasonal classification.
American Journal of Rhinology and Allergy, 2014, Volume 28(3):232-238(7)

Eitenmüller A, Piano L, Böhm M, Shah-Hosseini K, Glowania A, Pfaar O, Mösges R, Klimek L
Liposomal nasal spray versus guideline-recommended steroid nasal spray in patients with chronic rhinosinusitis: a comparison of tolerability and quality of life.
Journal of Allergy, Volume 2014 (2014), Article ID 146280

Dogan S, Astvatsatourov A, Deserno TM, Bock F, Shah-Hosseini K, Michels A, Mösges R
Objectifying the Conjunctival Provocation Test: Photography-Based Rating and Digital Analysis.
International Archives of Allergy and Immunology, 2014; 163(1):59-68

2013

Larenas-Linnemann D, Dinger H, Shah-Hosseini K, Michels A, Mösges R; Mexican Study Group on Allergic Rhinitis and SPT Sensitivity
Over diagnosis of persistent allergic rhinitis inpatients: A nationwide study in Mexico.
American Journal of Rhinology and Allergy, 2013 Nov;27(6):495-501.

Büttner L, Achilles N, Böhm M, Shah-Hosseini K, Mösges R
Efficacy and tolerability of bromelain in patients with chronic rhinosinusitis - a pilot study.
B-ENT, 2013;9(3):217-25.

Eichel A, Wittig J, Shah-Hosseini K, Mösges R
A prospective, controlledstudy of SNS01 (ectoine nasal spray) compared to BNO-101 (phytotherapeutic dragées) in patients with acute rhinosinusitis.
Current Medical Research and Opinion, Vol. 29, No. 7, 2013, 739-746.

Eberle P, Schreder H, Shah-Hosseini K, Mösges R
Medikamenten-Persistenz bei Kindern und Jugendlichen unter einer Langzeit-Hyposensensibilisierung mit Gräserpollenextrakten.
Allergologie, Jahrgang 36, Nr.1 /2013 S. 9-18.

2012

Eitenmüller A, Piano L, Böhm M, Shah-Hosseini K, Glowania A, Mösges R
Verträglichkeit und Auswirkungen auf die Lebensqualität durch die Behandlung mit einem liposomalen Nasenspray bei Patienten mit chronischer Rhinosinusitis.
Allergologie, Jahrgang 35, Nr. 9 /2012 S. 17-24.

2011

Sieber J, Shah-Hosseini K, Mösges R
Specific Immunotherapy for Allergic Rhinitis to Grass and Tree Pollens in Daily Medical Practice - Effectiveness of Sublingual Immunotherapy Compared to Subcutaneous Immunotherapy.
Annals of Medicine, 2011; 43: 418-424.

Mösges R, Nematian-Samani M, Hellmich M, Shah-Hosseini K
A meta-analysis of the efficacy of monotherapies in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa.
Current Medical Research and Opinion, Vol. 27, No. 10, 2011, 2053-2060.

Sieber J, De Geest S, Shah-Hosseini K, Mösges R
Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.
Current Medical Research and Opinion, Vol. 27, No. 4, 2011, 833-861.

Larenas-Linnemann D, Cruz A, Gutierrez IR, Rodriguez P, Shah-Hosseini K, Michels A, Mösges R
European and Mexican vs US diagnostic extracts of Bermuda grass and cat in skin testing.
Annals of Allergy, Asthma & Immunology, Volume 106, Issue 5, May 2011, Pages 421-428.

Sondermann N, Shah-Hosseini K, Henkel K, Schwalfenberg A, Mösges R
Erfolgsfaktoren der Adherence bei Hyposensibilisierung.
Allergologie, Jahrgang 34, Nr. 9 /2011 S. 441-446.

Karafyllakis S, Pupp J, Shah-Hosseini K, Grüttner B, Roethlisberger M, Mallmann P
Prädiktive geburtshilfliche Parameter der kindlichen Prognose bei extremer Frühgeburtlichkeit zwischen 22+0 und 25+6 SSW.
Z Geburtshilfe Neonatol 2011; 215 - PO08_09.

Karafyllakis S, Pupp J, Grüttner B, Shah-Hosseini K, Roethlisberger M, Mallmann P
s-flt/PIGF-Referenzwerte für Mehrlingsgraviditäten zur Prädiktion der Präeklampsie - s-flt Referenzbereich für normotone Mehrlingsgraviditäten.
Z Geburtshilfe Neonatol 2011; 215 - FV13_05.

2010

Sieber J, Gross A, Shah-Hosseini K, Mösges R
The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT.
Asian Pacific Journal of Allergy & Immunology, 2010 Dec;28(4):232-6.

Vogt K, Shah-Hosseini K, Mösges R, Pallanch J, Hasse W
New parameters in 4-phase-rhinomanometry, relations between objective findings and the sensation of obstruction. A statistical evaluation of 12580 cases.
Rhinology, 2010 / Suppl. 2: 25-31.

Larenas-Linnemann D, Matta JJ, Shah-Hosseini K, Michels A, Mösges R
Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United States.
Annals of Allergy, Asthma & Immunology, Volume 104, Issue 5, May 2010, Pages 420-425.

2009

Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno Aguilar C, Shah-Hosseini K, Mösges R
Safety of Two Cluster Schedules for Subcutaneous Immunotherapy in Allergic Rhinitis or Asthma Patients Sensitized to Inhalant Allergens.
International Archives of Allergy and Immunology, 2009; 150: 102-108.

2007

Herrmann G, Kais S, Hoffbauer J, Shah-Hosseini K, Brüggenolte N, Schober H, Fäsi M, Marbet P, Schaer P
Conserved interactions of the splicing factor Ntr1/Spp382 with proteins involved in DNA double-strand break repair and telomere metabolism.
Nucleic Acids Research, 2007; 35(7): 2321-32.

2006

Grosse Hovest M, Brüggenolte N, Shah-Hosseini K, Krieg T, Herrmann, G
Senescence of Human Fibroblasts after Psoralen Photoactivation is Mediated by ATR Kinase and Persistent DNA Damage Foci at Telomeres.
Molecular Biology of the Cell, 2006 Apr; 17(4): 1758-67.

 

Kongressbeiträge

2019

Möller J, Raskopf E, Greinert, O, Zadoyan G, Schleicher S, Shah-Hosseini K, Kelber O, Singh J, Mösges R, Kraft K, Nieber K
The Hypericum perforatum L. extract STW 3-VI in a large epidemiological study on the use of herbal medicinal products.
Zeitschrift für Phytotherapie, 2019, Georg Thieme Verlag KG, S. P20, doi:10.1055/s-0039-1697314

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Kraft K, Nieber K, Mösges R
Althaea officinalis root extract in the light of the PhytoVIS study, a NIS in 20,870 users of herbal medicinal products
Planta Medica, 2019, Georg Thieme Verlag KG, S. P-407, doi:10.1055/s-0039-3400118

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Kraft K, Nieber K, Mösges R
Data on Althaea officinalis L. root extract from the PhytoVIS study
Zeitschrift für Phytotherapie, 2019, Georg Thieme Verlag KG, S. P21, doi:10.1055/s-0039-1697315

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Kraft K, Nieber K, Mösges R
STW 5 in 1515 patients with functional gastrointestinal diseases
Planta Medica, 2019, Georg Thieme Verlag KG, S. P-422, doi:10.1055/s-0039-3400131

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Kraft K, Nieber K, Mösges R
Phytotherapy in children: Data from the PhytoVIS study, a NIS in 20,870 users of herbal medicinal products
Zeitschrift für Phytotherapie, 2019, Georg Thieme Verlag KG, S. V08, doi:10.1055/s-0039-1697279

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Mösges R, Nieber K
Therapie funktioneller Magen-Darm-Erkrankungen mit STW 5: Eine epidemiologische Erhebung mit 1515 Patienten
Zeitschrift für Phytotherapie, 2019, Georg Thieme Verlag KG, S. V09, doi:10.1055/s-0039-1697280

Möller J, Raskopf E, Greinert O, Zadoyan G, Schleicher S, Shah-Hosseini K, Wegener T, Kelber O, Singh J, Nieber K, Mösges R, Kraft K
Behandlung funktioneller Magen-Darm-Erkrankungen mit einem pflanzlichen Arzneimittel: Versorgungsforschung an 1515 Patienten
Zeitschrift für Gastroenterologie, 2019, Georg Thieme Verlag KG, S. KV 364, doi:10.1055/s-0039-1695464

Allekotte S, Grzella AN, Schleicher S, Shah-Hosseini K, Astvatsatourov A, Raskopf E, Mösges R
Non-pharmacological treatment with Liposomal Eye Spray Is As Effective As Antihistamine Eye Drops For The Relief Of Allergic Rhinoconjunctivitis Symptoms Induced By Conjunctival Provocation Testing.
Journal of Allergy and Clinical Immunology, Volume 143, Issue 2, Supplement, February 2019, Page AB174, doi.org/10.1016/j.jaci.2018.12.532.

2016

Singh J, Nohl A, Shah-Hosseini K, Pieper-Fuerst U, Compalati E, Mösges R
Effectiveness and tolerability of sublingual allergen Immunotherapy (AIT) with or without titration in routine medical practice in tree pollen allergic patients.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Lang S, Pieper-Fürst U, Reydelet Y, Astvatsatourov A, Shah-Hosseini K, Mösges R, Kramer MF, Pfaar O
Ultra-short-term revaccination using tyrosine-absorbed specific allergoids enhanced with monophosphoryl lipid A (MPL) as a highly effective option for treating recurrent grass pollen-induced allergic rhinitis.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Singh J, Kratel T, Weiher L, Shah-Hosseini K, Meiser P, Mösges R
Effects of Bromelain on cytokine concentrations in patients with chronic rhinosinusitis.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Zadoyan GV, Allekotte S, Shamji MH, Kasche EM, Shah-Hosseini K, Astvatsatourov A, Pirotton S, Legon T, Caplanusi A, Durham SR, Mösges R
Immunological biomarker predict clinical effects in subcutaneous peptide allergen immunotherapy.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Allekotte S, Liedtke J-P, Mandl A, Shah-Hosseini K, Pieper-Fürst U, Chwieralski J, Köther J, Mösges R
Comparison of the rhinitis control assessment test with more complex surveys for the evaluation of symptoms in patients suffering from allergic rhinitis.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Pieper-Fürst U, Kroh B, Reydelet Y, Shah-Hosseini K, Panin G, Lamprecht J, Mösges R
Noninterventional study on alpha-tocopherol acetate (vitamin E acetate) nasal spray as an alternative treatment option in patients with pollen-induced allergic rhinitis in comparison to standard therapies.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2016 in Vienna.

Allekotte S, Shamji MH, Zadoyan G, Kasche EM, Shah-Hosseini K, Astvatsatourov A, Pirotton S, Caplanusi A, Legon T, Durham SR, Mösges R
Facilitated Allergen Binding (FAB) Is a Meaningful Immunological Biomarker for Monitoring Immediate Clinical Efficacy in Short-Term Peptide Allergen Immunotherapy.
American Academy of Allergy, Asthma & Immunology (AAAAI), Congress 2016 in L.A.(USA).

2015

Lemberg M L, Eberle P, Shah-Hosseini K, Mösges R
Sublinguale immunotherapy: time to consider compliance and adherence.
Poster Allergiekongress in Köln 2015.

Nguyen M K, Mösges R, Hadler M, Karagiannis E, Hadler M, Shah-Hosseini K
Therapieadhärenz bei Patienten mit birkenpollenindizierter allergischer Rhinokonjunktivitis - Daten einer sublingualen Immuntherapie (SLIT) in der Routineversorgung.
Poster Allergiekongress in Köln 2015.

Krudewig E M, Shah-Hosseini K, Hadler M, Karagiannis E, Hadler M, Mösges R
Einflussfaktoren auf die Therapieadhärenz in der Routinebehandlung mit einer 5-Gräser-Tablette.
Poster Allergiekongress in Köln 2015.

Liedtke J P, Mandle A, Köther J, Chwieralski J, Shah-Hosseini K, Pieper-Fürst U, Allekotte S, Mösges R
Der Rhinitis Control Assessment Test im Vergleich mit erhebungsaufwendigeren Instrumenten zur Symptomabfrage der allergischen Rhinitis.
Poster Allergiekongress in Köln 2015

Hüser C, Dieterich P, Singh J, Astvatsourov A, Allekotte S, Shah-Hosseini K, Mösges R
Dosisfindungsstudie zur Wirksamkeit der SLIT mit monomeren Allergoid-Tabletten bei Patienten mit durch Hausstaubmilben verursachter allergischer Rhinokonjunktivitis.
Poster Allergiekongress in Köln 2015

Dieterich P, Hüser C, Singh J, Astvatsourov A, Allekotte S, Shah-Hosseini K, Mösges R
Konjunktivalen Provokationstest: Die Validierung des Prüfarzt-Ratings durch Foto-basierte zentrale Auswertung.
Poster Allergiekongress in Köln 2015

Kasche EM, Zadoyan G, Shamji MH, Corazza F, Shah-Hosseini K, Astvatsourov A, Durham SR, Pirotton S, Legon T, Mösges R
Hydrolyzed Iolium perenne leptitide fragments administrated subcutaneously to hay fever patients induce allergen-specific and blocking antibodies after two ore more weeks of treatment.
Poster Allergiekongress in Köln 2015

Zadoyan G, Sohlich L, Shah-Hosseini K, Astvatsourov A, Müller D, Kasche EM, Shamji MH, Durham SR, Pirotton S, Legon T, Mösges R
A prospective, randomized, double-blind placebo-controlled multi-centre dose-finding study of 3 different regimens of gpASIT+TM administered subcutaneously to adult patients with grass pollen-induced allergic rhinoconjunctivitis.
Poster Allergiekongress in Köln 2015

Diener I V, Zillmann R, Freiberg K, Stella J, Shah-Hosseini K, Berger-Schreck B, Wisplinghoff H, Lutz J T
Hautdesinfektion bei der Anlage von zentralvenösen und Periduralkathetern - Vergleich der bakteriellen Rekolonisierung bei alkoholischen und octenidinhaltigen Hautantiseptika.
Vortrag Diener I V, 62. Jahrestagung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin, DAC 2015.

Mösges R, Dieterich P, Hüser C, Singh J, Allekotte S, Shah-Hosseini K, Compalati E
A Randomized DBPC Dose-Finding Multicenter Trial of SLIT Allergoids Tablets in House Dust Mites (HDM) Allergic Patients.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2015 in Barcelona

De Marees M, Shah-Hosseini K, Karagiannis E, Mester J, Mösges R
Influence of allergic rhinitis (AR) on performance among athletes and their knowledge about allergen immunotherapy (AIT).
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2015 in Barcelona

Zadoyan G, Shah-Hosseini K, Astvatsourov A, Sohlich L, Kasche EM, Shamji MH, Durham SR, Pirotton S, Legon T, Mösges R
A prospective, randomized, double-blind placebo-controlled multi-centre dose-finding study of 3 different regimens of gpASIT+TM administered subcutaneously to adult patients with grass pollen-induced allergic rhinoconjunctivitis.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2015 in Barcelona

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
Multiple sublingual immunotherapies (SLIT) in polyallergic patients - real-life medical practice data.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2015 in Barcelona

Hadler M, Karagiannis E, Shah-Hosseini K, Mösges R
Clinical Outcome and Tolerability of a 2-Year Sublingual Allergen Immunotherapy (AIT) with a 5-Grass Pollen Tablet in Polyallergic Patients - Real-Life Medical Practice Data.
American Academy of Allergy, Asthma & Immunology (AAAAI), Congress 2015 in Houston

2014

Zadoyan G, Hauswald B, Yarin Y, Shah-Hosseini K, Shamji, MH, Durham SR, Pirotton S, Legon T, Mösges R
Safety, clinical tolerability and immunogenicity of increasing doses of gpASIT+TM administered subcutaneously to hay fever patients - a phase IIa dose-escalation study.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Karagiannis E, Hadler M, Shah-Hosseini K, Mösges R
Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy (AIT) in real-life medical practice in polyallergic patients with concomitant AIT or concomitant symptomatic medication.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Hadler M, Karagiannis E, Shah-Hosseini K, Mösges R
Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy (AIT) in children and adolescents allergic rhinoconjunctivitis caused by birch pollen.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Hadler M, Karagiannis E, Shah-Hosseini K, Mösges R
Full symptom control in patients with allergic rhinoconjunctivitis induced by birch pollen treated with sublingual allergen immunotherapy (AIT) in real-life medical practice.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Karagiannis E, Hadler M, Shah-Hosseini K, Mösges R
Treating grass pollen allergic patients with severe allergic rhinoconjunctivitis symptoms with 5-grass pollen tablets - results from a 2-year real-life medical practice study.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Eichel A, Kruse K, Gerwin E, Astvatsatourov A, Shah-Hosseini K, Mösges R
Conjunctival provocation tests: a predictive factor for patients’ seasonal allergic rhinoconjunctivitis symptoms.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Eichel A, Düster M, Astvatsatourov A, Shah-Hosseini K, Mösges R
Efficacy of LAIS birch-alder tablets in patients suffering from tree pollen-induced allergic rhinoconjunctivitis: a dose-finding study.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2014 in Copenhagen

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
2-year sublingual allergen immunotherapy (AIT) with 5-grass pollen tablets in children and adolescents with allergic rhinoconjunctivitis with and without allergic asthma - results from the OPTIMAL study.
Poster Congress of the European Society of Pediatric Otorhinolaryngology (ESPO 2014) in Dublin

2013

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
Non-interventional 2-year-study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen.
Poster Pediatric and Allergy Meeting (PAAM) Athens 2013

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
Asthmatic children and adolescents treated in daily medical practice - Results from a 2-year sublingual allergen immunotherapy (AIT) study with grass pollen tablets.
Poster Pediatric and Allergy Meeting (PAAM) Athens 2013

Shah-Hosseini K, Karagiannis E, Hadler M, Mösges R
Ergebnisse einer zweijährigen sublingualen Immuntherapie (SLIT) mit einer 5-Gräserpollen-Tablette in der Routineversorgung.
Poster Allergiekongress in Bochum 2013

Mösges R, Shah-Hosseini K, Hadler M, Karagiannis E
Vollständig kontrollierte Patienten in einer zweijährigen sublingualen Immuntherapie (SLIT) mit einer 5-Gräserpollen-Tablette in der Routineversorgung.
Poster Allergiekongress in Bochum 2013

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
Sublinguale Immuntherapie (SLIT) mit einer 5-Gräserpollen-Tablette in der Routineversorgung von Kindern und Jugendlichen mit Asthma -Resultate einer zweijährigen Beobachtungsstudie.
Poster Allergiekongress in Bochum 2013

Karagiannis E, Shah-Hosseini K, Hadler M, Mösges R
Ergebnisse einer zweijährigen sublingualen Immuntherapie (SLIT) mit einer 5-Gräserpollen-Tablette in der Routineversorgung von Kindern und Jugendlichen.
Poster Allergiekongress in Bochum 2013

Kruse K, Eichel A, Shah-Hosseini K, Mösges R
Zum prädiktiven Wert von präsaisonalen CPT-Ergebnissen für die Beschwerden bei allergischen Rhinitikern in der Birkenpollensaison.
Poster Allergiekongress in Bochum 2013

Düster M, Eichel A, Astvatsatourov A, Shah-Hosseini K, Mösges R
Dosisfindungsstudie zur Wirksamkeit von LAIS 2 Bäume Tabletten bei Patienten mit allergischer Rhinokonjunktivitis gegen Frühblüherpollen.
Poster Allergiekongress in Bochum 2013

Hadler M, Shah-Hosseini K, Karagiannis E, Mösges R
Sublinguale Immuntherapie (SLIT) bei allergischer Rhinokonjunktivitis in der Routineversorgung von Patienten mit Birkenpollenallergie.
Poster Allergiekongress in Bochum 2013

Hadler M, Shah-Hosseini K, Karagiannis E, Mösges R
Sublinguale Immuntherapie (SLIT) bei allergischer Rhinokonjunktivitis in der Routineversorgung von polyallergischen Patienten mit Birkenpollenallergie.
Poster Allergiekongress in Bochum 2013

Astvatsatourov A, Mösges R., Shah-Hosseini K, Dogan S
Standardisierung des konjunktivalen Provokationstests in der Allergiediagnostik.
Poster 84. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V. 2013 in Nürnberg

Larenas-Linnemann D E, Dinger H, Shah-Hosseini K, Michels A, Mösges R, Rodriguez Pérez N, Ambriz M, Nereida López D, Arias A, Pizano L, Monteverde Maldonado A, López J D R, Medina A, Garcia Imp D A, Mexican Study Group on Allergic Rhinitis and SPT Sensitivity
Persistent allergic rinitis was frequently over-diagnosed by specialists in a nationwide cross-sectional study.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

Dogan S, Astvatsatourov A, Deserno TM, Bock F, Shah-Hosseini K, Mösges R
Objectifying the conjunctival provocation test - photography-based rating and digital analysis.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

Karagiannis E, Hadler M, Shah-Hosseini K, Titova K, Mösges R
Non-interventional 2-year-study of sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by grass pollen.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

Karagiannis E, Hadler M, Shah-Hosseini K, Titova K, Mösges R
Full symptom control in patients with allergic rhinoconjunctivitis caused by grass pollen - results of a 2-year sublingual allergen immunotherapy (AIT) study.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

Hadler M, Karagiannis E, Shah-Hosseini K, Mösges R
Polyallergic patients treated in daily medical practice - results from a 2-year sublingual allergen immunotherapy (AIT) study with birch pollen extract.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

Hadler M, Karagiannis E, Shah-Hosseini K, Mösges R
Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy (AIT) in routine medical practice in birch pollen allergic patients.
Poster European Academy of Allergy and Clinical Immunology & World Allergy Organization Congress 2013 in Milan

2012

Karafyllakis S, Roethlisberger M, Shah-Hosseini K, Schaerfer S, Gruettner B, Einzmann T, Paporis P, Mallmann P
sFlt-1 und PlGF Level bei Gemini mit und ohne Präekalmpsie.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München

Karafyllakis S, Roethlisberger M, Shah-Hosseini K, Schaefer S, Matrai M, Puppe J, Fridman A, Gottschalk I, Mallmann P
Die Rolle der sFlt-1 und PlGF zur Prädiktion der postpartalen Blutung bei Zwillingsschwangerschaften mit und ohne Präeklampsie.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München

Karafyllakis S, Roethlisberger M, Shah-Hosseini K, Schierholz K, Richters L, Ratiu D, Paporis P, Mallmann P
Der Einfluss des Krankenversicherungsstatus am geburtshilflichen Notfall.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München

Karafyllakis S, Shah-Hosseini K, Roethlisberger M, Schierholz K, Puppe J, Ratiu D, Matrai M, Ludwig S, Lange N, Mallmann P
Zirkadianer Rhythmus der Entbindungen durch Notsectio.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München

Karafyllakis S, Shah-Hosseini K, Roethlisberger M, Boeckmann A, Einzmann T, Mallmann P
Ethnische Unterschiede in der Schwangerenvorsorge anhand eines Vergleichs von Mutterpässen zwischen Schwangeren mit und ohne Migrationshintergrund.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München

Karafyllakis S, Roethlisberger M, Shah-Hosseini K, Gottschalk I, Gruettner B, Appel S, Enninga I, Fridman A, Paporis P, Richters L, Fridrich C, Mallmann P.
Bei welchem Schwangerschaftsintervall ist der Stellenwert der Marker sFlt-1 und PlGF für die Differentialdiagnose am größten?
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München.

Karafyllakis S, Shah-Hosseini K, Roethlisberger M, Enninga I, Gruettner B, Fridrich C, Puppe J, Malter W, Einzmann T, Matrai M, Appel S, Mallmann P.
Unterschiede zwischen SIH und Präeklampsie in den Levels der Angiogenesefaktoren sFlt-1 und PlGF.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München.

Karafyllakis S, Shah-Hosseini K, Roethlisberger M, Enninga I, Fridman A, Ludwig S, Lange N, Puppe J, Gottschalk I, Paporis P, Einzmann T, Appel S, Mallmann P.
Der Stellenwert der Marker sFlt-1 und PlGF zur Prädiktion der verbleibenden Schwangerschaftsdauer bei Präeklampsie.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München.

Karafyllakis S, Roethlisberger M, Shah-Hosseini K, Enninga I, Fridman A, Einzmann T, Appel S, Mallmann P.
Die Angiogenesefaktoren sFlt-1 und PlGF beim HELLP Syndrom.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München.

Karafyllakis S, Shah-Hosseini K, Roethlisberger M, Schierholz K, Puppe J, Ratiu D, Matrai M, Ludwig S, Lange N, Mallmann P.
Der Einfluss der EE-Zeit auf das kindliche Outcome bei Notsectio.
Poster Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2012 in München.

Gerwin E, Rohdenburg C, Eichel A, Shah-Hosseini K, Mösges R.
Zum prädiktiven Wert konjunktivaler Provokationen für die Symptomlast in der Saison.
Poster Allergiekongress in München 2012.

Eichel A, Rohdenburg C, Shah-Hosseini K, Mösges R.
Dosisfindungsstudie zur Wirksamkeit von LAIS®Gräser Tabletten bei Patienten mit durch Gräserpollen verursachter allergischer Rhinokonjunktivitis.
Poster Allergiekongress in München 2012.

Karagiannis E, Hadler M, Shah-Hosseini K, Titova K, Mösges R.
Sublinguale Immuntherapie (SLIT) mit der 5-Gräserpollen-Tablette in der Routineversorgung von Patienten mit unterschiedlichen klinischen Profilen.
Poster Allergiekongress in München 2012.

Titova K, Karagiannis E, Hadler M, Shah-Hosseini K, Mösges R.
Compliance und Verträglichkeit der sublingualen Immuntherapie (SLIT) mit der 5-Gräserpollen-Tablette in der Routineversorgung in Deutschland.
Poster Allergiekongress in München 2012.

Karagiannis E, Hadler M, Oppermann M, Shah-Hosseini K, Mösges R.
Sublinguale Immuntherapie (SLIT) mit einem Birkenpollenextrakt in der Routineversorgung - Bewertung von Verträglichkeit, Patientenbefinden und Compliance.
Poster Allergiekongress in München 2012.

Hadler M, Karagiannis E, Oppermann M, Shah-Hosseini K, Mösges R.
Sublinguale Immuntherapie (SLIT) bei allergischer Rhinokonjunktivitis in der Routineversorgung von Patienten mit Birkenpollenallergie.
Poster Allergiekongress in München 2012.

Shah-Hosseini K, Karagiannis E, Hadler M, Oppermann M, Mösges R.
Sublinguale Immuntherapie (SLIT) mit einem Birkenpollenextrakt bei Kindern und Jugendlichen - Ergebnisse aus der Routineversorgung.
Poster Allergiekongress in München 2012.

Dinger H, Mösges R, Michels A, Shah-Hosseini K, Larenas Linnemann D, Mexican Study Group on Allergic Rhinitis and Allergen Sensitization.
Topographical profile of allergic rhinoconjunctivitis with coexisting asthma in a nation-wide study in Mexico.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2012 in Geneva.

Larenas Linnemann D, Mexican Study Group on Allergic Rhinitis and Allergen Sensitization, Michels A, Dinger H, Shah-Hosseini K, Mösges R.
Allergen sensitization patterns in Mexican patient with rhinitis symptoms: a prospective nation-wide study.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2012 in Geneva.

Karagiannis E, Hadler M, Oppermann M, Shah-Hosseini K, Mösges R.
Sublingual immunotherapy (SLIT) with birch pollen extract in daily medical practice - assessments of tolerability, patients’ well-being, and adherence.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2012 in Geneva.

Hadler M, Karagiannis E, Oppermann M, Shah-Hosseini K, Mösges R.
Effectiveness of sublingual immunotherapy (SLIT) in daily medical practice in patients with allergic rhinoconjunctivitis related to birch pollen.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2012 in Geneva.

2011

Eitenmüller A, Piano L, Böhm M, Shah-Hosseini K, Glowania A, Klimek L, Mösges R.
Verträglichkeit und Auswirkungen auf die Lebensqualität durch die Behandlung mit einem liposomalen Nasenspray bei Patienten mit chronischer Rhinosinusitis.
Poster Allergiekongress in Wiesbaden 2011.

Hahn C, Böhm M, Shah-Hosseini K, Mösges R.
Vergleich der Verträglichkeit und der Auswirkungen auf die Lebensqualität der Behandlungsmethode mit einem liposomalen Nasenspray gegenüber der Anwendung Dexpanthenol-haltiger Nasensalbe bzw. isotonem NaCl-Spray bei Patienten mit Rhinitis sicca.
Poster Allergiekongress in Wiesbaden 2011.

Shah-Hosseini K, Kerkojus S, Wenzeler A, Mösges R.
Einfluss der sublingualen Immuntherapie mit LAIS-Gräsertabletten auf das Beschwerdeprofil der Patienten bei co-saisonaler Behandlung.
Poster "Allergologie im Kloster" Eberbach 2011.

2009

Sieber J, Shah-Hosseini K, Mösges R.
Seasonal SLIT clearly improves quality of life of grass pollen allergic patients- evaluation in daily life setting.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2009 in Warsaw.

Sieber J, Shah-Hosseini K, Mösges R.
Grass pollen SIT in daily medical practice - effectiveness of sublingual immunotherapy is comparable with subcutaneous treatment.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2009 in Warsaw.

Larenas Linnemann D, Matta-Campos J, Shah-Hosseini K, Michels A, Mösges R.
The biologic potency by skin prick testing (SPT) of a US diagnostic allergen extracts of Dermatophagoides pteronyssinus is two-fold higher compared to European and Mexican extracts.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2009 in Warsaw.

2008

Sieber J, Shah-Hosseini K, Mösges R.
Reasons for Drop-outs in SCIT in daily medical practice - Results from an observational study.
Poster European Academy of Allergy and Clinical Immunology (EAACI), Congress 2008 in Barcelona.